Gatenby, Piers A <br/><br/>
Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort.  [electronic resource] 

 -  European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)  Sep 2009 
 - 381-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5709 
<br/><br/><label>Standard No.: </label>10.1097/CEJ.0b013e32832e0955  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--epidemiology<br/>Anticarcinogenic Agents--therapeutic use<br/>Aspirin--therapeutic use<br/>Barrett Esophagus--drug therapy<br/>Cohort Studies<br/>Demography<br/>Esophageal Neoplasms--epidemiology<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Precancerous Conditions--drug therapy